Korean J Physiol Pharmacol.
1997 Feb;1(1):27-34.
Pharmacological evidence that cromakalim inhibits Ca2+ release from
intracellular stores in porcine coronary artery
- Affiliations
-
- 1Department of Pharmacology, College of Medicine, Pusan National University, Pusan South Korea.
Abstract
-
In the present study, it was aimed to further identify the
intracellular action mechanism of cromakalim and levcromakaliin in the
porcine coronary artery. In intact porcine coronary arterial strips
loaded with fura-2/AM, acetylcholine caused an increase in
intracellular free Ca2+ ((Ca2+)-i) in association with a contraction
in a concentration-dependent manner. Cromakalim (1 micrometer) caused a
reduction in acetylcholine-induced increased (Ca2+)-i not only in the
normal physiological salt solution (PSS) but also in Ca2+ -free PSS
(containing 1mM EGTA). In the skinned strips prepared by exposure of
tissue to 20 micrometer beta-escin, inositol 1,4,5-trisphosphate (IP-3)
evoked an increase in (Ca2+)-i but it was without effect on the intact
strips. The IP-3-induced increase in (Ca2+)-i was inhibited by
cromakalim by 78% and levcromakalim by 59% (1 micrometer, each). Pretreatment
with glibenclamide (a blocker of ATP-sensitive K+ channels, 10 micrometer and
apamin (a blocker of small conductance Ca2+/-activated K+ channels, 1
micrometer strongly blocked the effect of cromakalim and levcromakalim.
However, charybdotoxin (a blocker of large conductance Ca2+ -activated
K+ channels, 1-micrometer) was without effect. In addition, cromakalim
inhibited the GTP-gamma-S (100 micrometer, nonhydrolysable analogue of
GTP)-induced increase in (Ca2+)-i. Based on these results, it is
suggested that cromakalim and levcromakalim exert a potent
vasorelaxation, in part, by acting on the K+ channels of the
intracellular sites (e.g., sarcoplasmic reticulum membrane), thereby,
resulting in decrease in release of Ca2+ from the intracellular
storage site.